pSivida Corp

Press Releases

All Releases
View Summary pSivida Reports ILUVIEN® Receives Marketing Authorization in Two More EU Countries
Jan 26, 2015
PDF 15.3 KB Add to Briefcase
View Summary pSivida Reports Commencement of ILUVIEN® Sales in Portugal
Jan 14, 2015
PDF 15.9 KB Add to Briefcase
View Summary pSivida Reports ILUVIEN® Granted Marketing Authorization in the Netherlands
Dec 1, 2014
PDF 15.5 KB Add to Briefcase
View Summary pSivida CEO to Present at LD Micro Investor Conference
Nov 26, 2014
PDF 15.5 KB Add to Briefcase
View Summary pSivida Reports ILUVIEN® Granted Marketing Authorization in Ireland
Nov 17, 2014
PDF 15.6 KB Add to Briefcase
View Summary pSivida Reports ILUVIEN® Granted Marketing Authorization in Belgium
Nov 12, 2014
PDF 15.6 KB Add to Briefcase
View Summary pSivida Corp. Reports First Quarter FY 2015 Results
Nov 7, 2014
PDF 26.3 KB Add to Briefcase
View Summary pSivida Corp. Announces First Quarter Fiscal 2015 Financial Results Release Date and Conference Call Information
Oct 31, 2014
PDF 16.2 KB Add to Briefcase
View Summary pSivida Corp. Receives $25 Million Milestone Payment
Oct 27, 2014
PDF 15.8 KB Add to Briefcase
View Summary pSivida Corp. Reports FDA Approval of ILUVIEN® for Diabetic Macular Edema
Sep 26, 2014
PDF 21.1 KB Add to Briefcase
View Summary pSivida Corp. Names James Barry to Board of Directors
Sep 10, 2014
PDF 17.1 KB Add to Briefcase
View Summary pSivida Corp. Reports Fourth Quarter and FY 2014 Results
Sep 9, 2014
PDF 29.1 KB Add to Briefcase
View Summary pSivida Corp Announces Fourth Quarter and Fiscal Year 2014 Financial Results Release Date and Conference Call Information
Sep 3, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Sweden, 10th EU Approval
Sep 3, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Denmark, 9th EU Approval
Jul 31, 2014
PDF 16.4 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal
Jul 28, 2014
PDF 16.7 KB Add to Briefcase
View Summary pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for Marketing Authorizations in 10 More EU Countries
Jun 30, 2014
PDF 17.2 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® Receives Marketing Authorization in Italy for Treatment of Chronic Diabetic Macular Edema
Jun 23, 2014
PDF 15.8 KB Add to Briefcase
View Summary pSivida Corp. Reports Third Quarter 2014 Results
May 13, 2014
PDF 29.9 KB Add to Briefcase
View Summary pSivida Presents Preclinical Data Demonstrating Sustained Release of Avastin Using Tethadur at ARVO Annual Meeting
May 5, 2014
PDF 16.3 KB Add to Briefcase
Showing 61-80 of 270 Page: 1 2 3 4 5 6 7 8 ... 14  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida